Radius Health Reports Fourth Quarter and Full Year 2014 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Radius Health (RDUS) PT Lifted to $56 at Jefferies; Potentially Early Efficacy Data for RAD1901 at ASCO
March 11, 2015 7:35 AM EDTJefferies analyst Eun K. Yang reiterated a Buy rating and lifted the price target on Radius Health (NASDAQ: RDUS) to $56.00 (from $45.00) following in-line Q4 results but potentially early efficacy data for RAD1901 at ASCO.
Yang commented, "With positive, clean Ph3 data for... More
Radius Health (RDUS) Reports Narrower Q4 Loss Than Expected
March 10, 2015 8:51 AM EDTRadius Health (NASDAQ: RDUS) reported Q4 EPS of ($0.55), $0.08 better than the analyst estimate of ($0.63).
For earnings history and earnings-related data on Radius Health (RDUS) click here.
... More